The significant flotation of Elon Musk's SpaceX on the Nasdaq has led to an estimated £270 million in British retail investment flowing across the Atlantic, with London's junior market, AIM, experiencing a notable drain. Since the June 12 listing, the AIM All-Share Index has seen a decline of approximately 2.4 percent. The impact is further illustrated by a decrease in traded volume, which has fallen by around 13-14 percent compared to the same period last year.
SpaceX's offering was the largest Initial Public Offering in history, with a substantial portion of shares allocated to ordinary investors. The outflow of capital appears to have particularly affected companies valued between £50 million and £200 million. In this segment, low trading volumes can exacerbate price volatility and create difficulties for buyers and sellers in agreeing on a valuation. This trend suggests that increased accessibility to global markets has provided investors with alternative destinations for their capital, rather than stimulating new interest in London.
In the past week, the AIM All-Share Index continued its downward trend, falling 0.6 percent on thin trading volumes. In contrast, the FTSE 100 index rose by 2.3 percent, supported by positive trading updates from various companies.
Several individual companies on the AIM market have faced significant challenges. Shares in CAP-XX, a supercapacitor maker, dropped 43 percent this week following a £2.2 million fundraising through a placing and subscription. This decline is attributed to a combination of discount pricing and dilution, with the funds intended for upgrades and expansion of production lines, customer acquisition, and general working capital.
Shield Therapeutics also saw its shares fall 34 percent after a trading update. While the half-year financial figures appeared strong, they were bolstered by a one-time $7.9 million payment from the company's Chinese partner. Excluding this payment, quarterly sales actually decreased, and the price of its main drug was affected by stricter Medicaid rules in New York. Investors are also monitoring the company's cash position, which has declined by approximately $4 million in three months.
AB Dynamics, a specialist in vehicle testing, experienced a 30 percent slide in its share price after warning that customers are delaying orders due to difficulties faced by European car manufacturers. Restructuring and logistical issues in the Middle East have slowed decision-making, impacting sales of testing products and simulation. The firm now anticipates lower revenue, is exiting a loss-making unit in China, and has cited a more challenging second half of the year.
On a more positive note, Sunda Energy's shares surged 44 percent after its chief executive, Andy Butler, purchased the remaining £400,000 of convertible loan notes associated with the company's New Zealand acquisition. Butler has indicated no plans to convert these notes into shares, a move interpreted by investors as a strong show of confidence.
Shearwater Group shares rose 31 percent following the cyber-security firm's announcement that revenue and profits are expected to exceed City forecasts. The company anticipates full-year revenue of around £42 million, driven by its services division and recent contract wins. This positive outlook coincides with heightened concerns over cyber security, following reports of unauthorized access to systems by advanced AI models from OpenAI and Anthropic. The increasing demand for cyber defenses has fueled investor interest in Shearwater Group.
Getech's stock jumped 30 percent after Xcalibur Multiphysics, a Spanish firm specializing in airborne surveys for resource mapping, acquired a 25.5 percent stake in the company. Getech, which utilizes geological data for natural resource and green energy exploration, is seen as a complementary partner, leading to speculation of a potential takeover.
Itaconix shares have continued to climb, extending a monthly gain of 60 percent. The company's performance has been driven by an upbeat trading update on July 17, which indicated first-half sales increased by 72 percent to a record $8.3 million. Itaconix has raised its full-year guidance to at least $14.8 million, surpassing previous analyst estimates. Growth has been attributed to repeat detergent orders and new customers in Europe and North America, signaling increasing commercial traction for the company.